Investors tracking shares of Nektar Therapeutics (NKTR) may be focusing on where the stock is trading relative to its 52-week high and low. At the time of writing, the stock had recently reached at $20.29. At this price, shares can be seen trading -56.93% off of the 52-week high mark and 29.77% away from the 52-week low. Investors often pay increased attention to a stock when it is nearing either mark. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. It has a market cap of $3.54B.
Volume Evaluation
Active moving action has been spotted in Nektar Therapeutics (NKTR) on Friday as stock is moving on change of -1.22% from the open. The US listed company saw a recent price trade of $20.29 and 1174924 shares have traded hands in the session. There are 3.56M shares which are traded as an average over the last three months period.
Trading volume can help an investor identify momentum in a stock and confirm a trend. If trading volume increases, prices generally move in the same direction. That is, if a security is continuing higher in an uptrend, the volume of the security should also increase and vice versa. Trading volume can also signal when an investor should take profits and sell a security due to low activity. If there is no relationship between the trading volume and the price of a security, this signals weakness in the current trend and a possible reversal.
Performance Levels
Looking performance record on shares of Nektar Therapeutics (NKTR) we observed that the stock has seen a move -47.37% over the last 52-week trading period. The stock generated performance of 15.48% tracking last 3 months and -40.43% over the recent 6 months. Investors will be anxiously watching to see if things will turn around and the stock will start gaining or losing momentum over the next few months. If we look back year-to-date, the stock has performed -38.27%. Shares are at 0.87% over the previous week and 15.61% over the past month.
Analyst Views: Fluctuating the focus to what the Wall Street analysts are projecting, we can see that the current consensus target price on shares is $32.38. Analysts often put in a lot of work to study stocks that they cover. Wall Street analysts have a consensus recommendation of 2.4 on this stock. This number falls on a one to five scale where a 1 would be considered a strong buy and 5 means a strong sell, 2 shows Buy, 3 Hold, 4 reveals Sell recommendation.
Volatility Insights
Watching some historical volatility numbers on shares of Nektar Therapeutics (NKTR) we can see that the 30 days volatility is presently 5.56%. The 7 days volatility is 4.26%. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.
The company has a beta of 2.58. 1.00 indicates that its price is correlated with the market. Less than 1.00 shows less volatility than the market. Beta greater than 1.00 indicates that the security’s price is theoretically more volatile than the market.
The Average True Range (ATR) value reported at 0.99. The average true range (ATR) is a technical analysis indicator that measures volatility by decomposing the entire range of an asset price for that period. A stock experiencing a high level of volatility has a higher ATR, and a low volatility stock has a lower ATR. The ATR may be used by market technicians to enter and exit trades, and it is a useful tool to add to a trading system. It was created to allow traders to more accurately measure the daily volatility of an asset by using simple calculations. The indicator does not indicate the price direction; rather it is used primarily to measure volatility caused by gaps and limit up or down moves. The ATR is fairly simple to calculate and only needs historical price data.
Technical Considerations
Nektar Therapeutics (NKTR) stock positioned -27.39% distance from the 200-day MA and stock price situated 10.02% away from the 50-day MA while located 4.25% off of the 20-day MA. Nektar Therapeutics (NKTR) traded moved -9.74% from the 50-day high price and spotted a change of 29.77% from the 50-day low point.
RSI value sited with reading of 56.56. RSI readings range from zero to 100, with readings above 70 generally interpreted as indicating overbought conditions and readings below 30 indicating oversold conditions. Since the RSI measures the magnitude of recent price movements, it is most prone to generating false signals following sudden, sizable price changes. Generally, as the price of stock rises, the RSI will rise as well, because average gains will outstrip average losses. When the stock price falls, losses typically outstrip gains, causing the indicator to fall.
Charles Frey
Category - Business
After many years in the market, Charles Frey dedicated all his time to write articles highlighting different financial problems. He has worked as financial analyst until his retirement. He is a well-known research director and portfolio manager for more than 5 years.
Charles holds a postgraduate degree in Software Engineering. ‘The stock market is filled with individuals who know the price of everything, but the value of nothing.’ Charles is a share market expert, being personally invested for over 6 years. He has been writing his entire life, and while he has made a career of business and finance reporting, he still enjoys writing short stories and poetry.
Address: 2520 North Van Buren Street, Wilmington, DE 19802, USA
Email: [email protected]
Zip code: 19802
Contact # 302-298-6858